BusinessOcera to Present at the 15th Annual Needham Healthcare ConferenceBy Nasdaq OMXApr 5, 2016, 8:25 PM UTC
BusinessU.S. Food and Drug Administration Grants Orphan Drug Designation to Adaptimmune’s T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue SarcomaBy Nasdaq OMXMar 30, 2016, 11:40 AM UTC
BusinessBioMarin Receives European Orphan Drug Designation for BMN 270, First Investigational AAV-Factor VIII Gene Therapy for Patients with Hemophilia ABy Nasdaq OMXMar 24, 2016, 12:30 PM UTC
BusinessOcera to Present at the 18th Annual BIO CEO & Investor ConferenceBy Nasdaq OMXFeb 2, 2016, 9:20 PM UTC
BusinessArQule Provides Proprietary Pipeline Update for AKT InhibitorsBy Nasdaq OMXJan 28, 2016, 12:30 PM UTC
BusinessOcera Announces Complete Plasma Data From Pilot Phase 1 Study for Orally-Available OCR-002 in Development for the Prevention of Chronic Hepatic EncephalopathyBy Nasdaq OMXJan 8, 2016, 2:05 PM UTC
